Pure Speculation

Pure Speculation

As the Tandem (NASDAQ: TNDM) death watch continues and now that Johnson and Johnson (NYSE: JNJ) has decided to abandon diabetes it’s beginning to dawn on some people that we soon could live in a world with just two insulin pump companies – Medtronic (NYSE: MDT) and Insulet (NASDAQ: PODD). Ok to be fair Roche also has a pump only problem is they no market presence. Also, to be fair Bigfoot is working on a system but it isn’t here yet. Plus, there is growing belief that patients can achieve optimum control using a CGM smart insulin pen system . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.